Posted on June 1, 2012December 1, 2017 by adminJune 2012 Greyrock provides $5.1 million of subordinated debt and equity to support a family office’s acquisition of Pharmaco, a company focused on acquiring and developing pharmaceuticals used to treat life-threatening diseases.